Erratum: Prediction of high-risk Ewing's sarcoma by gene expression profiling

被引：0

作者：

Anat Ohali

Smadar Avigad

Rina Zaizov

Ron Ophir

Shirley Horn-Saban

Ian J Cohen

Isaac Meller

Yehuda Kollender

Josephine Issakov

Isaac Yaniv

机构：

来源：

Oncogene | 2005年 / 24卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Correction to: Oncogene (2004) 23, 8997–9006. doi:10.1038/sj.onc.1208060 Published online 27 September 2004 Since publication of the above manuscript, the authors have identified an error in Figure 5. The revised version of the figure is given below.

引用

页码：4319 / 4319

共 50 条

[41] On expression of Survivin in Ewing's Sarcoma Cell lines
Sheikh-Mounessi, F.
Willich, N.
Greve, B.
STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 149 - 149
[42] C-kit expression in Ewing's sarcoma
Ahmed, A
Lacson, A
Gilbert-Barness, E
Chamizo, W
Washington, K
LABORATORY INVESTIGATION, 2002, 82 (01) : 1P - 1P
[43] Expression of ADAMTS4 in Ewing's sarcoma
Minobe, K.
Ono, R.
Matsumine, A.
Shibata-Minoshima, F.
Izawa, K.
Oki, T.
Kitaura, J.
Iino, T.
Takita, J.
Iwamoto, S.
Hori, H.
Komada, Y.
Uchida, A.
Hayashi, Y.
Kitamura, T.
Nosaka, T.
INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (03) : 569 - 581
[44] Outcome and prognostic factors in children with high-risk Ewing's sarcoma treated with high-dose chemotherapy and autologous stem cell rescue
Lassaletta, A
Gonzalez-Vicent, M
Perez, A
Blumenfeld, JA
Sevilla, J
Madero, L
Diaz, MA
BONE MARROW TRANSPLANTATION, 2006, 37 : S150 - S150
[45] Erratum: Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma
Y Jethava
A Mitchell
M Zangari
S Waheed
C Schinke
S Thanendrarajan
J Sawyer
D Alapat
E Tian
C Stein
R Khan
C J Heuck
N Petty
D Avery
D Steward
R Smith
C Bailey
J Epstein
S Yaccoby
A Hoering
J Crowley
G Morgan
B Barlogie
F van Rhee
Blood Cancer Journal, 2016, 6 : e471 - e471
[46] Expression profiling of Kaposi's Sarcoma
O'Donovan, M
Silva, I
Sheils, OM
O'Leary, JJ
LABORATORY INVESTIGATION, 2002, 82 (01) : 307A - 307A
[47] Expression profiling of Kaposi's Sarcoma
O'Donovan, M
Silva, I
Sheils, OM
O'Leary, JJ
MODERN PATHOLOGY, 2002, 15 (01) : 307A - 307A
[48] p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma
Qasim, Shawki L.
Sierra, Laura
Shuck, Ryan
Kurenbekova, Lyazat
Patel, Tajhal D.
Rajapakshe, Kimal
Wulff, Jade
Nakahata, Kengo
Kim, Ha Ram
Landesman, Yosef
Unger, T. J.
Coarfa, Cristian
Yustein, Jason T.
ONCOGENE, 2021, 40 (06) : 1176 - 1190
[49] p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma
Shawki L. Qasim
Laura Sierra
Ryan Shuck
Lyazat Kurenbekova
Tajhal D. Patel
Kimal Rajapakshe
Jade Wulff
Kengo Nakahata
Ha Ram Kim
Yosef Landesman
T. J. Unger
Cristian Coarfa
Jason T. Yustein
Oncogene, 2021, 40 : 1176 - 1190
[50] HIGH-RISK EWING SARCOMA - END-INTENSIFICATION USING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
MARCUS, RB
GRAHAMPOLE, JR
SPRINGFIELD, DS
FORT, JA
GROSS, S
MENDENHALL, NP
ELFENBEIN, GJ
WEINER, RS
ENNEKING, WF
MILLION, RR
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (01): : 53 - 59

← 1 2 3 4 5 →